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Summary: Catecholamines have been implicated in the modulation of normal cell growth, exerting inhibitory or 
excitatory control depending on the cell type. However, there is a dearth of information on the role of adrenergic mediators 
in gastric cell proliferation. In the present study, the effects of adrenaline (ADR) and noradrenaline (NOR) on mucosal cell 
growth and the cell cycle were evaluated in vitro using a normal rat gastric mucosal cell line RGM-1. Cell proliferation 
was assessed using [3H]-thymidine incorporation and cell cycle patterns were determined by DNA labeling with propidium 
iodide and flow cytometric quantification. The expressions of adrenoceptors in RGM-1 were determined by Western blot. 
ADR (0.01 – 10µM) and NOR (0.01 – 10µM) inhibited the growth of RGM-1 cells in a concentration-dependent manner. 
Pre-treatment of cells with ADR and NOR also inhibited the proliferation stimulated by epidermal growth factor (EGF). 
Neither phentolamine (non-selective α-adrenergic blocker), methoxamine (α1-selective agonist) nor clonidine (α2-selective 
agonist) significantly affected the inhibition of cell proliferation produced by ADR and NOR.  Propranolol (non-selective 
β-adrenergic blocker) and butoxamine (selective β2-adrenergic blocker) significantly (but not totally) reversed the 
inhibitory action of ADR on cell proliferation. Furthermore, procaterol (selective beta-2 agonist) but not dobutamine 
(selective beta-1 agonist) had effects similar to those produced by ADR and NOR. Exposure of RGM-1 cells to both ADR 
and NOR caused significant inhibition of the G1 – S cycle progression as evidenced by the higher percentage of the G0/G1 
phase and a decreased S- phase. This effect was blocked by pre-treatment with propranolol but not phentolamine These 
results indicate that catecholamines inhibit the proliferation of RGM-1 cells probably partly through beta-2 receptors. 
©Physiological Society of Nigeria 
 
Keywords: Cathecholamines; RGM-1; Cell proliferation; cell cycle; flow cytometry, [3H]-thymidine 
 
*Address for correspondence: . sb.olaleye@mail.ui.edu.ng 
 
Telephone: +234-802-3255893 Fax: +234-02-8100826 
 
Manuscript accepted: June 2010  
 
INTRODUCTION 
 
The gastric fundic mucosa is regarded as a self-
renewing epithelium, undergoing rapid cell 
proliferation in response to assaults from foods, drugs 
and an array of endogenous substances. It is 
estimated that the turn-over rate of the progenitor 
zone in the isthmus is about 33 – 40% per day 
(Karam and Leblond, 1993; Karam et al, 2003). The 
importance of the isthmal cell proliferation lies in the 
fact that by the process of migration and 
differentiation, they give rise to the functional cell 
lineages in the oxyntic mucosa such as the neck cells 
(for mucous secretion) and parietal cells (for acid 
secretion). 
 Several factors have been shown to be involved 
in the control of normal gastric epithelial cell 
proliferation. These include growth factors such as 
epidermal growth factor (Sasaki et al, 2003), 
transforming growth factor-alpha (TGF-α) (Chen et 
al, 1993)] and tumor necrosis factor-alpha (TNF-α) 
(Luo et al, 2005); hormones such as gastrin (Li and 
Hellander 1996), somatostatin (Lehy et al, 1979), 
erythropoietin (Itoh et al, 2006) and other 
endogenous peptides such as nitric oxide (Baatar et 
al, 2003) and prostaglandins (Sasaki et al, 2003). 
 Catecholamines have been implicated in the 
modulation of normal cell proliferation, exerting 
inhibitory or excitatory control depending on the cell 
type. Leicht et al (2003) observed that norepinephrine 
stimulated cardiac fibroblasts through the regulation 
of mitogen-activated protein kinase [MAPK]. 
Similarly, catecholamines stimulate proliferation of 
brown adipocytes (Thonberg et al, 2001), osteoblasts 
(Suzuki et al, 1998), proximal tubule cells (Cussac et 
al, 2002) as well as corneal epithelial cells (Jones and 
Marfurt, 1996). On the other hand, catecholamines 
inhibit the proliferation of lymphocytes (Sampere et 
al, 2004). 
 The effect of the adrenergic neurotransmitters on 
the gastrointestinal cell proliferation is also not 
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generalized. Thus, isoprenaline stimulates murine 
salivary acinar cell proliferation (Zeng et al, (1976) 
but inhibits proliferation of cells in the buccal 
epithelium of rats (McInnes 1976). As a result of this 
non-uniformity in the actions of adrenergic receptor 
stimulants, it is difficult to make a sweeping 
generalization of the role of these neurotransmitters 
on cell proliferation. This fact, coupled with the 
dearth of adequate information on the exact role of 
the adrenergic system in gastric cell proliferation, 
prompted the present study. 
 The progression of proliferating cells through the 
cell cycle is dependent upon the interplay of activities 
of cyclin-dependent kinases (cdk) and their 
regulatory subunits [cyclins] to enable cells progress 
from the G1 to S-phase (G1-S transition) and from 
G2 to M phase (G2-M transition) (Sherr and Roberts, 
1995; 2004). The synthesis of appropriate cyclins 
during a specific phase is required for progression to 
take place. Therefore, the inhibition of a needed 
cyclin may result in the arrest of the cycle in a 
particular phase (Nakayama et al, 1996; Bartek and 
Lukas). 
 The aims of the present study are: to evaluate the 
capacity of two naturally occurring catecholamines to 
modulate gastric cell proliferation, to identify the 
adrenergic receptors involved in such activity, to 
assess the effects of the catecholamines on gastric 
epithelial cell cycle progression. 
 
 
MATERIALS AND METHODS 
 
Reagents:  
Epinephrine (ADR), norepinephrine (NOR), 
propranolol (PRP), phentolamine (PHENT), 
clonidine (CLON), methoxamine (METH), 
dobutamine (DOBUT), procaterol (PROCAT) and 
propidium iodide (PI) were all purchased from Sigma 
Chemical Co. (St. Louis, MO). A 1:1 mixture of 
Dulbecco's modified Eagle's medium and Ham's F-12 
medium (DMEM/F12) was purchased from Life 
Technologies (Invitrogen catalog number 11320-
033). Fetal Bovine Serum (FBS), Hank’s Balance 
Salt Solution (HBSS) and Trypsin-EDTA were 
purchased from Gibco BRL (Grand Island, NY). 
Other reagents were of analytical grade and obtained 
from Sigma-Aldrich Inc (St. Louis, MO, USA), 
unless otherwise stated 
 
Cell culture:  
Rat gastric mucosal epithelial cell line RGM-1 (RCB-
0876, Riken Cell Bank, Tsukuba, Japan), a diploid, 
non-transformed epithelial line isolated from normal 
Wistar rat’s gastric mucosa (Kobayashi et al, 1996) 
was used for this study. The cells were grown in 
DMEM/F-12 medium containing 20% heat-
inactivated, fetal bovine serum and supplemented 
with 100U/ml penicillin G, 100 μg/ml streptomycin, 
and 20% FBS in an incubator at 37°C, 95% humidity, 
and 5% CO2. Cells were routinely subcultured in 
15ml medium in Iwaki flasks using trypsin/EDTA. 
Cultures were examined regularly under an inverted 
light microscope to monitor growth and rule out 
contamination. For this study, data for passages 9 – 
22 were found to be consistent and were thus used. 
 
Assessment of RGM-1 cell membrane integrity:  
The degree of cellular necrosis in RGM-1 cells was 
estimated by measuring the level of lactate 
dehydrogenase (LDH) released into the culture 
media. RGM-1 cells were seeded to a subconfluent 
density of 4 x104 cells/well in 24-well plates (IWAKI 
Inc, Japan) and incubated overnight in DMEM F-12 
supplemented with 20% FBS for adherence. The cells 
were then exposed to catecholamines at 10-fold 
dilutions ranging from 0.001 μM to 10 μM. Control 
cells were inoculated with DMEM F12 only (negative 
control) or DMEM + 1% Triton X (positive control). 
Incubation was performed for 24h in triplicate. At the 
end of each incubation, culture medium was 
centrifuged at 250 x g for 5 minutes a (at 40C) and 
100μL aliquot transferred to a clean 96-well Iwaki 
plate. The amount of LDH released into the culture 
media was quantified using a commercial kit (LDH-
Cytotoxic Test; Wako, Osaka, Japan) 
 
Cell Proliferation::  
Basal and Epidermal Growth Factor (EGF) 
stimulated proliferative responses of cultured rat 
gastric epithelial cells RGM-1 to catecholamines 
were determined by [3H]-thymidine incorporation. 
Briefly, RGM-1 cells were seeded in 24-well culture 
plates at ~5×104 cells/ml and were allowed to grow 
in DMEM/F-12 medium containing 20% FBS for 24 
h. Afterwards, cells were growth arrested in serum-
free medium overnight and then treated with ADR or 
NOR [0.1uM – 10uM] in the presence or absence of 
inhibitors for 6, 12, 18 and 24 hr. In experiments 
involving the evaluation of adrenergic 
agonist/antagonist interactions, antagonists were 
added to the culture medium 45 minutes prior to the 
agonists. Five hours prior to final analysis, the cells 
were further incubated with [3H]-thymidine (0.5 
μCi/ml). 
 After washing each well with ice-cold Normal 
Saline and detaching the cells from culture  plates, 
the radioactivity of each sample were measured using 
a liquid scintillation counter (LS-6500, Beckman 
Instruments, Inc., Pullerton, CA). 
 
 
Cell cycle analysis::  
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The effect of catecholamines on the distribution of 
cell cycle phases was determined by flow cytometry 
using a Beckman-Coulter FACScan. Cells were 
plated at 5 × 105 cells in 60mm diameter plates in 2 
ml of DMEM-F12 medium supplemented with 20% 
FBS. After reaching about 50% confluence, the cells 
were synchronized in the G0 phase by incubation in a 
serum-free medium for 48h. The cells were then 
treated with ADR or NOR in the presence or absence 
of adrenergic inhibitors. After 24h of incubation, cells 
were harvested and washed with PBS, resuspended in 
500 μl of PBS, and fixed in 500 μl of ice-cold 
absolute ethanol at −20 °C. After incubation for 30 
min, cell pellets were collected by centrifugation, 
resuspended in 0.5 ml of PBS containing 100 μg/ml 
RNase, and incubated at 37 °C for 30 min. 
 Then 0.5 ml of propidium iodide [PI] solution (50 
μg/ml in PBS) was added, and the mixture was 
allowed to stain on ice for 60 min. The cells were 
analyzed with FACScan flow cytometer (Becton 
Dickinson, USA). For each experiment, a total of 104 
cells were counted. 
 Analysis of the flow cytometry result was done 
using Cychred and WinMDI (Purdue University) 
software. 
 
Western blot analysis:  
RGM-1 cells were seeded in 100-mm plates at a 
density of 5 x 106. Cells were harvested by cell 
scraping, collected by centrifugation, and the pellet 
was washed once with PBS and then lysed in a lysis 
buffer composed of Mg2+- and Ca2+- free 
phosphate-buffered saline (PBS) supplemented with 
20 mM Tris-HCl, pH 8.0, 1% NP40, 150 mM NaCl, 1 
mM EDTA, 10% glycerol, 0.1% ß-mercaptoethanol, 
0.5 mM dithiothreitol, and a mixture of proteinase 
inhibitors consisting of 1 mM phenylmethylsulfonyl 
fluoride, 10 mg/ml aprotinin, 5 mg/ml leupeptin, 5 
mM benzamidine, 1 mg/ml pepstatin, 2 mg/ml 
antipain hydrochloride (Boehringer, Mannheim, 
Germany), 50 mM 4-[2-aminoethyl]-benzenesulfonyl 
fluoride hydrochloride (Wako Pure Chemical 
Industries Ltd., Osaka, Japan) and 2 mM sodium 
orthovanadate (Sigma-Aldrich). The lysate containing 
15 μg protein was electrophoresed in a 10-20% 
gradient SDS-PAGE mini gel (Dai-ichi Kagaku, 
Tokyo, Japan) and blotted onto a PVDF membrane 
using Multiphor II (Amersham Pharmacia Biotech, 
Buckinghamshire, UK) for 30 min. The blotted 
membrane was blocked with 5% skim milk in 10 mM 
Tris-HCl, pH 7.2, containing 150 mM NaCl and 0.5% 
Tween 20 and incubated with primary antibodies 
(0.1-1 mg/ml) described below at 4°C for 16 h. The 
membrane was then incubated with alkaline 
phosphatase-conjugated secondary antibodies (0.02 
mg/ml), described below, for 4 h at room 
temperature. The membrane was rinsed, treated with 
nitroblue tetrazolium (Sigma-Aldrich) and 5-bromo-
4-chloro-3-indolyl phosphate (Sigma-Aldrich) to 
visualize protein bands. The primary antibodies used 
were mouse anti-human monoclonal antibody against 
β1 and β2 adrenergic receptors (Transduction 
Laboratories, San Diego, CA, USA) and goat 
polyclonal antibodies against human actin (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA). The 
secondary antibodies used were anti-mouse and anti-
goat IgGs conjugated with alkaline phosphatase 
(Santa Cruz). The intensity of each band was imaged 
and the bands were observed to ascertain the presence 
of beta adrenoceptors on RGM-1 cells. 
 
Statistical analysis 
The data are presented as the mean ± SEM of each 
experimental point. One-way ANOVA was used to 
compare data between 3 or more groups. Differences 
among groups were examined using the Student's t-
test when the F value was significant. Values are 
expressed as mean standard error of the mean [SEM] 
while the level of significance was set at P < 0.05. 
 
 
RESULTS 
 
Cytotoxicity studies 
To select the non-cytotoxic concentrations of the 
catecholamines for the experiment, the release of 
lactate dehydrogenase (LDH) from RGM-1 cells in 
response to different concentrations of 
cathecholamines was determined. As shown in Fig. 1, 
LDH release by RGM-1 cells was not significantly 
altered by catecholamine concentrations up to 10μM. 
However, significant increases in LDH release were 
observed at concentrations of 100μM and above. For 
the subsequent studies therefore, a concentration 
range of 0.01μM to 10μM was used. The positive 
control 1% Triton X-100 markedly increased LDH 
release for more than 2 folds. 
 
Proliferation studies 
 
a. Effects of catecholamines on unstimulated 
proliferation of RGM-1 cells 
As shown in Fig. 2, exposure of RGM-1 cells to 
graded concentrations of ADR and NOR [0.01 – 
10μM] for 12, 18 and 24 h caused a time- and dose-
dependent inhibition of DNA synthesis. For the 6 h 
culture, neither ADR nor NOR had any significant 
effect on RGM-1 cell proliferation at the doses tested. 
However, for the 18 h culture, cell proliferation was 
significantly inhibited at the two highest 
concentrations [P <0.05] without affecting cell 
viability. Maximal inhibition was however obtained 
after 24 h of exposure to ADR and NOR at 
concentrations of 0.01μM (P < 0.05), 0.1μM and 1.0 
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μM (P < 0.001). Therefore a concentration of 1.0 μM 
at 24 h exposure time was used in subsequent 
mechanistic experiments. When compared with NOR, 
there was no significant differences in the inhibitory 
pattern of ADR 
 
b. Effects catecholamines on EGF-induced 
proliferation of RGM-1 cells 
Exposure of cells to ADR and NOR for 24 h also 
dose-dependently inhibited proliferation induced by a 
known mitogen, epidermal growth factor.  
As shown in Fig. 3, exposure of RGM-1 cells to EGF 
(0.1 ng/ml) increased [3H]-thymidine incorporation 
to 162.81±1.02% over the control value (P < 0.001). 
Pre-treatment of the cells with ADR before 
incubation with EGF significantly reduced this 
stimulation to 142.5± 5.47 at the 0.01 μM 
concentration and to 105.08 ± 4.54 for the 10 μM 
concentration (Fig 3a). Similar pattern was obtained 
for the noradrenaline experiment (Fig. 3b). 
 
 
Fig. 1 
LDH release in RGM-1 Cells treated with graded concentrations of Catecholamines. Each vertical bar represents Mean ± 
SEM of six experiments per treatment. Triton X served as positive control. 
 
 
   
Fig. 2  
Effects of adrenaline (a) and noradrenaline (b) on [3H]-thymidine incorporation into RGM-1 cell line. Approximately 4 x 
105 RGM-1 cells were added to flat bottom 24-well plates. Data represent the means of three independent experiments and 
were compared using the two-tailed Student t-test. * P<0.05; ** P<0.005 
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Fig. 3 
Adrenaline (a) and noradrenaline (b) inhibit EGF-induced [3H]-thymidine incorporation into RGM-1 cell line in a dose 
dependent mamnner. Approximately 4 x 105 RGM-1 cells were added to flat bottom 24-well plates. Data represent the 
means of three independent experiments and were compared using the two-tailed Student t-test. * P<0.05 ** P<0.005 (c.f 
EGF treated group). 
 
c. Effects of non-selective adrenoceptor antagonists 
on the inhibitory action of catecholamine on RGM-1 
cell proliferation 
Exposure of RGM-1 cells to 1.0 μM the non-selective 
alpha adrenergic antagonist, phentolamine, prior to 
ADR treatment did not significantly affect the 
inhibitory activity of ADR on cell proliferation (Fig. 
4a).  
However, when the cells were exposed to similar 
concentrations of propranolol, a non-selective beta 
adrenergic antagonist prior to ADR treatment, there 
was a significant change in the inhibitory action of 
ADR on cell proliferation from 75.17 ± 2.53% [for 
ADR alone] to 94.22 ± 3.43% [for ADR + PRP], Fig. 
4b. 
d. Effects of selective beta-adrenoceptor antagonists 
on the inhibitory action of catecholamine on RGM-1 
cell proliferation 
Based on the results from the experiments in (c) 
above, we investigated the role of specific beta 
adrenoceptor blocking drugs atenolol (β1) and 
butoxamine (β2) on the inhibitory action of ADR. 
The results are presented in Fig. 5. Exposure of the 
RGM-1 cells to atenolol or butoxamine alone did not 
have any significant effects on the incorporation of 
thymidine. Also, pre-treatment of cells with atenolol 
did not alter the inhibitory activity of ADR on 
thymidine incorporation. However, exposure of the 
cells to butoxamine before ADR significantly 
reversed the inhibitory action of ADR to levels 
comparable to the control values. 
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Fig. 4 
Effects of pre-treatment with Phentolamine (a) and propranolol (b) on adrenaline-induced inhibition of RGM-1 cell 
proliferation. *P< 0.05; NSNot significant (Compared with control values) 
 
 
e. Effects of selective adrenergic agonists on the 
proliferation of RGM-1 cells 
To further confirm the involvement of adrenoceptors 
on the actions of ADR and NOR, the effects of 
selective agonists of the adrenoceptors on RGM-1 
cell proliferation were investigated. Neither 
methoxamine (alpha-1 selective agonist) nor 
clonidine (alpha-2 selective agonist) significantly 
affected RGM-1 cell proliferation to any significant 
level (Fig. 6a).  
 
The effects of the selective beta-1 agonist, 
dobutamine and beta-2 agonist, procaterol on cell 
proliferation are also shown in Fig. 4b. While 
dobutamine did not alter thymidine incorporation 
significantly at the dose tested, procaterol produced 
significant inhibition (Fig. 6b). 
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Cell cycle studies 
 
 The effects of ADR and NOR on the cell cycle of 
RGM-1 were determined by flow cytometry. As 
shown in Fig.7a & b, ADR caused accumulation of 
cells in the G0-G1 phase population cell cycle. In the 
control cells, the G0-G1 phase population was 60.13 
± 1.70% of the total cell population. The G0-G1 
phase in the 0-1μM ADR and 0.1 μM NOR treated 
cells were 71.20 ± 1.39% (P < 0.05) and 68.13 + 
0.96% (P < 0.05) respectively. 
 Furthermore, the population of cells in the S-
phase of the cells of cycle was significantly decreased 
by catecholamine treatment reducing to 30.07 ± 2.31 
(P < 0.05) and 25.00 ± 1.13% in cells pre-exposed to 
0.1 μM ADR and 0.1 μM NA respectively. 
 Fig 8 shows the effect of pre-treatment of RGM-1 
cells with phentolamine (alphaadrenoceptor 
blocker) and propranolol (beta-adrenoceptor) blocker 
on cell cycle distribution. Phentolamine did not 
significantly reverse the effects of ADR on the G0-
G1 phase (71.20 ± 1.39%) for ADR c.f. 69.43 ± 
2.05% for ADR+PHENT. On the other hand, the 
propranolol significantly reversed the effects of ADR 
(71.20 ± 1.39% for ADR cf. 63.8 ± 1.9% for 
ADR+PROP). These results suggest that the 
accumulation of G0-G1 phase cells induced by 
catecholamine treatment may be mediated via the 
beta-adrenoceptor mechanism.  
 
 
 
 
Fig. 5 
Effects of selective β1-adrenoceptor (atenolol) and β2-adrenoceptor (butoxamine) antagonists on [3H]-thymidine 
incorporation into RGM-1 cell line. Approximately 4 x 105 RGM-1 cells were added to flat bottom 24-well plates. Data 
represent the means of three independent experiments and were compared using the two-tailed Student t-test. * P<0.05, 
NSNot significant (Compared with control values). 
 
 
 
0
20
40
60
80
100
120
Co
nt
ro
l
AD
R 
(1u
M
)
AT
EN
 (1
uM
)
AD
R(
1u
M
) +
 A
TE
N(
1u
M
)
AD
R(
1u
M
)
BU
TO
X(
1u
M
)
AD
R(
1u
M
)+
BU
TO
X(
1u
M
)
[3
H
]-
th
ym
id
in
e 
in
co
rp
or
at
io
n 
(%
 c
on
tr
ol
)
* *
*
NS NS
NS
Nig. J, Physiol. Sci. 25 (2010): Olaleye, Wu and Cho 
12 
Catecholamines and gastric cell proliferation 
 
Fig. 6 
Selective α1 adrenoceptor (methoxamine) and α2 
(clonidine) agonists did not alter [3H]-thymidine 
incorporation into RGM-1 cell line (a) while the selective 
β2-adrenoceptor agonist, procaterol significantly inhibited 
thymidine incorporation (b).   
 
Expression of Beta-adrenoceptors 
Western blot analysis of protein samples from RGM-
1 cells (Fig. 9) revealed a faint expression of beta-1 
adrenergic receptors. On the other hand, beta-2 
adrenoceptors were clearly expressed 
 
DISCUSSION 
 
In the present study, we have demonstrated that 
catecholamines caused inhibition of cellproliferation 
in the rat gastric mucosal cell lines in a dose-
dependent manner. Results from the study also 
suggest that the observed effects of catecholamine on 
cell proliferation are evoked by beta-2 adrenoceptors, 
as suggested by the inhibitory activity of the non-
selective beta-adrenergic antagonist, propranolol and 
the selective beta-2 adrenergic antagonist, 
butoxamine. Western blot analysis also indicated the 
presence of beta-2 adrenoceptors in RGM-1 cells. 
The implication of the present result is discussed 
based on the known gastrointestinal processes 
affected directly or indirectly by changes in cell 
proliferation. 
 Growth factors have been shown to play 
important roles in the maintenance of gastrointestinal 
tissue integrity, repair of gastrointestinal mucosal 
injury as well as ulcer healing. Such actions are 
particularly well documented for epidermal growth 
factor (EGF) (Basson et al, 1992; Tarnawski et al, 
1995; Majumdar et al, 1996). This is corroborated in 
the present study in which EGF dose-dependently 
increased thymidine incorporation into RGM-1 cells. 
It is significant to note that both ADR and NOR 
produced greater inhibition of EGFstimulated 
response than the basal state. It is therefore possible 
that a major locus of the inhibitory action of the 
catecholamines is the EGF-stimulatory pathways. 
 The integrity of the gastric mucosa is maintained 
by the interplay of anti-proliferative forces such as 
the number of apoptotic cells and the pro-
proliferative forces. When the kinetic balance is tilted 
towards cell proliferation excessive growth of the 
gastric mucosa cells occur. A number of proliferation 
promoting substance, such as ethanol (Ge et al, 2007; 
Hernandez –Munoz et al, 2000) and Helicobacter 
pylori (Eslick et al, 1999) have been shown to 
predispose the stomach to chronic gastritis (Lynch et 
al, 1995; Cahill et al, 1996) and even gastric cancer 
(Parsonnet et al, 1991; Honda et al, 1998; Kamada et 
al, 1995). 
 In the present study, the proliferative effect of the 
potent mitogen, EGF was significantly inhibited by 
adrenaline and noradrenaline. The action of 
catecholamine may thus be used to explain the 
formation of stress induced gastric ulcers. Stress 
induced ulcers have been produced in several models 
in experimental animals using catecholamines 
(Beraha, 1980; Man, 1981).  
 The inhibition of the activity of growth factors 
under stressful conditions may explain in part the 
higher predisposition of the stomach wall to erosion. 
Cell proliferation is also important in ulcer healing 
process. It is known that failure of DNA synthesis 
characterize intractable ulcers (Kobayashi et al, 
1998). The repair process in gastric mucosa injury 
involves an initial reconstitution of the epithelial 
surface via cell migration from gastric pits and glands 
(Svanes, 1982) and later by increased cell 
proliferation to replace lost cells (Silen et al, 1987; 
Tarnawski et al, 2000). Previous reports show that 
though EGF is produced in the salivary glands under 
normal conditions, it is also secreted at ulcer margins, 
causing not only migration, but also rapid 
proliferation of cells (Konturek et al, 1990). The high 
expression of EGF at ulcer margins was reported by 
Ma et al (Ma et al, 2000). EGF has also been shown 
to play significant roles in the healing of stress-
induced ulcers (Konturek et al, 2000). 
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Fig. 7.  
The distribution of cell cycle in Adrenaline (ADR) treated RGM-1 cells (A) and Noradrenaline (NA) treated cells (B). The 
distribution of cell cycle was assessed by flow cytometry. The data shown are the mean ± SEM three independent 
experiments, each with triplicate wells. The asterisk indicates a significant difference between control and treated cells, (P< 
0.05). NS = Not significant (c.f. control) 
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Fig. 8 
Effects of pre-treatment with phentolamine or propanolol on the distribution of cell cycle in Adrenaline (ADR) treated 
RGM-1 cells . The distribution of cell cycle was assessed by flow cytometry. The data shown are the mean ± SEM three 
independent experiments, each with triplicate wells. The asterisk indicates a significant difference between control and 
treated cells, (P< 0.05). NS = Not significant (c.f. control) 
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Fig. 9 
A Western blot analysis of 1-AR and 2-AR expression in RGM-1 cell line demonstrating relative distribution of expected 
protein size for 1-AR (50 kDa), 2-AR (65 kDa). 
 
 
 Following our observation that the catecholamine 
inhibits gastric cell proliferation, we investigated the 
biochemical aspects of the signaling mechanism that 
may be responsible for this action. When the 
functional analyses of the adrenergic receptors 
involved were carried out, it was observed that most 
of the inhibitory actions of catecholamine were 
contributed by the β2 adrenoceptors. A number of 
studies have shown that the adrenoceptors are 
involved in modulating cell proliferation in a number 
of cells in the gastrointestinal tract. For example, 
catecholamines have been reported to stimulate 
proliferation of the intestinal epithelium through 
activation of 2 adrenoceptors located on crypt cells 
(Schaak et al, 2000) whereas catecholamines inhibit 
cell proliferation in the buccal epithelium of rat via 
β2 adrenoceptors (McInnes and Tutton, 1976). 
Although the actions of adrenaline and noradrenaline 
on cell proliferation was inhibited by the β2 
adrenoceptor blocker, the possibility of the 
involvement of other beta adrenoceptor subtypes not 
investigated in this study should not be ruled out. 
 Thus further investigations into the role β3 
adrenoceptors in gastric epithelial cell proliferation 
may be necessary. It may be concluded from this 
study that catecholamines inhibit the proliferation of 
gastric mucosal cells. In addition, beta adrenoceptor 
subtypes are involved, at least in part, in this process. 
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